The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy.
Saved in:
| Title: | The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. |
|---|---|
| Authors: | Reader CS; Centre for Tumour Biology, Barts Cancer Institute, CRUK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, UK., Vallath S; Centre for Tumour Biology, Barts Cancer Institute, CRUK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, UK., Steele CW; Cancer Research UK Beatson Institute, Glasgow, UK., Haider S; Institute of Cancer Research, London, UK., Brentnall A; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK., Desai A; Centre for Tumour Biology, Barts Cancer Institute, CRUK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, UK., Moore KM; Centre for Tumour Biology, Barts Cancer Institute, CRUK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, UK., Jamieson NB; Academic Unit of Surgery, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK., Chang D; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Bailey P; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Scarpa A; ARC-NET Research Centre for Applied Research on Cancer, University of Verona, Verona, Italy., Lawlor R; ARC-NET Research Centre for Applied Research on Cancer, University of Verona, Verona, Italy., Chelala C; Centre for Molecular Oncology, Barts Cancer Institute, CRUK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, UK., Keyse SM; Division of Cancer Research, University of Dundee, James Arrott Drive, Ninewells Hospital and Medical School, Dundee, UK., Biankin A; Centre for Molecular Oncology, Barts Cancer Institute, CRUK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, UK., Morton JP; Cancer Research UK Beatson Institute, Glasgow, UK., Evans TJ; Cancer Research UK Beatson Institute, Glasgow, UK.; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Barry ST; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK., Sansom OJ; Cancer Research UK Beatson Institute, Glasgow, UK., Kocher HM; Centre for Tumour Biology, Barts Cancer Institute, CRUK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, UK., Marshall JF; Centre for Tumour Biology, Barts Cancer Institute, CRUK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, UK. |
| Source: | The Journal of pathology [J Pathol] 2019 Nov; Vol. 249 (3), pp. 332-342. Date of Electronic Publication: 2019 Jul 30. |
| Publication Type: | Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley And Sons Country of Publication: England NLM ID: 0204634 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9896 (Electronic) Linking ISSN: 00223417 NLM ISO Abbreviation: J Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31259422 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Reader+CS%22">Reader CS</searchLink>; Centre for Tumour Biology, Barts Cancer Institute, CRUK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, UK.<br /><searchLink fieldCode="AU" term="%22Vallath+S%22">Vallath S</searchLink>; Centre for Tumour Biology, Barts Cancer Institute, CRUK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, UK.<br /><searchLink fieldCode="AU" term="%22Steele+CW%22">Steele CW</searchLink>; Cancer Research UK Beatson Institute, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Haider+S%22">Haider S</searchLink>; Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Brentnall+A%22">Brentnall A</searchLink>; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Desai+A%22">Desai A</searchLink>; Centre for Tumour Biology, Barts Cancer Institute, CRUK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, UK.<br /><searchLink fieldCode="AU" term="%22Moore+KM%22">Moore KM</searchLink>; Centre for Tumour Biology, Barts Cancer Institute, CRUK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, UK.<br /><searchLink fieldCode="AU" term="%22Jamieson+NB%22">Jamieson NB</searchLink>; Academic Unit of Surgery, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Chang+D%22">Chang D</searchLink>; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Bailey+P%22">Bailey P</searchLink>; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Scarpa+A%22">Scarpa A</searchLink>; ARC-NET Research Centre for Applied Research on Cancer, University of Verona, Verona, Italy.<br /><searchLink fieldCode="AU" term="%22Lawlor+R%22">Lawlor R</searchLink>; ARC-NET Research Centre for Applied Research on Cancer, University of Verona, Verona, Italy.<br /><searchLink fieldCode="AU" term="%22Chelala+C%22">Chelala C</searchLink>; Centre for Molecular Oncology, Barts Cancer Institute, CRUK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, UK.<br /><searchLink fieldCode="AU" term="%22Keyse+SM%22">Keyse SM</searchLink>; Division of Cancer Research, University of Dundee, James Arrott Drive, Ninewells Hospital and Medical School, Dundee, UK.<br /><searchLink fieldCode="AU" term="%22Biankin+A%22">Biankin A</searchLink>; Centre for Molecular Oncology, Barts Cancer Institute, CRUK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, UK.<br /><searchLink fieldCode="AU" term="%22Morton+JP%22">Morton JP</searchLink>; Cancer Research UK Beatson Institute, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Evans+TJ%22">Evans TJ</searchLink>; Cancer Research UK Beatson Institute, Glasgow, UK.; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Barry+ST%22">Barry ST</searchLink>; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Sansom+OJ%22">Sansom OJ</searchLink>; Cancer Research UK Beatson Institute, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Kocher+HM%22">Kocher HM</searchLink>; Centre for Tumour Biology, Barts Cancer Institute, CRUK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, UK.<br /><searchLink fieldCode="AU" term="%22Marshall+JF%22">Marshall JF</searchLink>; Centre for Tumour Biology, Barts Cancer Institute, CRUK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220204634%22">The Journal of pathology</searchLink> [J Pathol] 2019 Nov; Vol. 249 (3), pp. 332-342. <i>Date of Electronic Publication: </i>2019 Jul 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+And+Sons%22">John Wiley And Sons </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0204634 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-9896 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200223417%22">00223417 </searchLink><i>NLM ISO Abbreviation: </i>J Pathol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31259422 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/path.5320 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 332 Titles: – TitleFull: The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Reader CS – PersonEntity: Name: NameFull: Vallath S – PersonEntity: Name: NameFull: Steele CW – PersonEntity: Name: NameFull: Haider S – PersonEntity: Name: NameFull: Brentnall A – PersonEntity: Name: NameFull: Desai A – PersonEntity: Name: NameFull: Moore KM – PersonEntity: Name: NameFull: Jamieson NB – PersonEntity: Name: NameFull: Chang D – PersonEntity: Name: NameFull: Bailey P – PersonEntity: Name: NameFull: Scarpa A – PersonEntity: Name: NameFull: Lawlor R – PersonEntity: Name: NameFull: Chelala C – PersonEntity: Name: NameFull: Keyse SM – PersonEntity: Name: NameFull: Biankin A – PersonEntity: Name: NameFull: Morton JP – PersonEntity: Name: NameFull: Evans TJ – PersonEntity: Name: NameFull: Barry ST – PersonEntity: Name: NameFull: Sansom OJ – PersonEntity: Name: NameFull: Kocher HM – PersonEntity: Name: NameFull: Marshall JF IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2019 Nov Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1096-9896 Numbering: – Type: volume Value: 249 – Type: issue Value: 3 Titles: – TitleFull: The Journal of pathology Type: main |
| ResultId | 1 |